Related references
Note: Only part of the references are listed.Mobilization of qnrB2 and ISCR1 in Plasmids
Ying-Tsong Chen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Selection of SHV extended-spectrum-β-lactamase-dependent cefotaxime and ceftazidime resistance in Klebsiella pneumoniae requires a plasmid-borne blaSHV gene
David S. Harnmond et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Mosaic structure of p1658/97, a 125-kilobase plasmid harboring an active amplicon with the extended-spectrum β-lactamase gene blaSHV-5
M. Zienkiewicz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Multiple Antimicrobial Resistance in Plague: An Emerging Public Health Risk
Timothy J. Welch et al.
PLOS ONE (2007)
Regional variation in the prevalence of extended-spectrum β-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002)
Y Hirakata et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2005)
Evolutionary mapping of the SHV β-lactamase and evidence for two separate IS26-dependent blaSHV mobilization events from the Klebsiella pneumoniae chromosome
PJ Ford et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
SHV-1 β-lactamase is mainly a chromosomally encoded species-specific enzyme in Klebsiella pneumoniae
J Chaves et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
High-level expression of chromosomally encoded SHV-1 β-lactamase and an outer membrane protein change confer resistance to ceftazidime and piperacillin-tazobactam in a clinical isolate of Klebsiella pneumoniae
LB Rice et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
